Aldevron announced today its new fermentation capacity of 1,000 liters and plans to significantly increase the Company’s manufacturing footprint in Madison, WI. The large-scale fermentation equipment is already installed and will be coming on-line in Q4 2019.
James Brown, Ph.D., presenting "Standardized Plasmids for Viral Vector Production" tech talk at American Society of Gene & Cell Therapy Annual Meeting
Representatives from Aldevron will attend the 22nd Annual Meeting for the American Society of Gene & Cell Therapy (ASGCT), April 29 - May 2, 2019, in Washington, D.C.
Dr. Victoria Sowemimo has joined Aldevron as its new Director of Quality Assurance. In her position, Sowemimo will lead the company’s cGMP Quality Assurance functions supporting through all phases of clinical and commercial product release, management of Aldevron’s quality systems and regulatory training to assure compliance to all phase appropriate requirements pertaining to Good Manufacturing Practices.
Michael Jablon of Aldevron has been named Senior Director of Information Systems. In this position, Jablon will lead Information Systems initiatives to improve efficiency, streamline operations, optimize information security and design innovative systems that will enable Aldevron’s clients to more rapidly advance treatments and gene therapies for their patients.